1 March 2006
New York State Department of Health - State/Local Government Agency [U.S.]
Summary,

GUIDELINE OBJECTIVE(S)

To provide guidelines for diagnosis and treatment of anxiety disorders in patients with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) in primary care settings

TARGET POPULATION

Patients with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) in primary care settings with suspected anxiety disorder

INTERVENTIONS AND PRACTICES CONSIDERED

Diagnosis

• Consideration of signs and symptoms
• Distinguishing among anxiety disorders and excluding underlying medical conditions such as human immunodeficiency virus (HIV)-related central nervous system disease, endocrinopathies, cardiovascular and other conditions that may cause anxiety
• Reviewing patients' medication regimens and obtaining a thorough substance use history

Treatment/Management

• Referring patients who use substances or whose anxiety is persistent or severe and does not respond to standard treatment to mental health professionals
• Providing psychological support
• Medications, including benzodiazepines, selective serotonin re-uptake inhibitors (SSRIs), and tricyclic antidepressants

MAJOR OUTCOMES CONSIDERED

Not stated